Lexicon Pharmaceuticals (LXRX) Tax Provisions (2010)
Lexicon Pharmaceuticals' (LXRX) quarterly Tax Provisions came in at -$26000.0 in Q3 2010.
Lexicon Pharmaceuticals (LXRX) Tax Provisions (2010) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has 1 years of Tax Provisions data on file, last reported at -$26000.0 in Q3 2010.
- On a quarterly basis, Tax Provisions changed N/A year-over-year to -$26000.0 in Q3 2010; TTM through Dec 2011 was -$26000.0, a N/A change from a year earlier, with the FY2014 full-year figure at -$70000.0, changed N/A from the prior year.
- Tax Provisions for Q3 2010 stood at -$26000.0.
- Over the last five years, Tax Provisions for LXRX reached as high as -$26000.0 in Q3 2010 and fell as low as -$26000.0 in Q3 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Lexicon Pharmaceuticals | 922.55 Mn | 751.90 Mn | 20.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2010 | -26,000.00 |